Creative Medical Technology Holdings Inc.

$CELZ is leading the Prism MarketView Biotech index today after the company announced it had received FDA authorization for an expanded access therapy using CELZ-201.

Share This Article

 

About the Author

Creative Medical Technology Holdings Inc.

Joey Ramson